Mucormycosis

G Reid, JP Lynch III, MC Fishbein… - Seminars in respiratory …, 2020 - thieme-connect.com
Mucormycosis is an infection caused by a group of filamentous molds within the order
Mucorales. Infections may result from ingestion of contaminated food, inhalation of spores …

Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic

A Sharma, A Goel - Folia Microbiologica, 2022 - Springer
Mucormycosis is a deadly opportunistic disease caused by a group of fungus named
mucormycetes. Fungal spores are normally present in the environment and the immune …

[HTML][HTML] Infections after lung transplantation

M Nosotti, P Tarsia, LC Morlacchi - Journal of thoracic disease, 2018 - ncbi.nlm.nih.gov
The good clinical result of lung transplantation is constantly undermined by the high
incidence of infection, which negatively impacts on function and survival. Moreover …

[HTML][HTML] Lung transplantation: a treatment option in end-stage lung disease

M Hartert, Ö Senbaklavaci, B Gohrbandt… - Deutsches Ärzteblatt …, 2014 - ncbi.nlm.nih.gov
Background Lung transplantation is the final treatment option in the end stage of certain lung
diseases, once all possible conservative treatments have been exhausted. Depending on …

Lung transplantation for cystic fibrosis: results, indications, complications, and controversies

JP Lynch III, DM Sayah, JA Belperio… - … in respiratory and …, 2015 - thieme-connect.com
Survival in patients with cystic fibrosis (CF) has improved dramatically over the past 30 to 40
years, with mean survival now approximately 40 years. Nonetheless, progressive respiratory …

Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis

JP Lynch III, MC Fishbein, F Abtin… - Expert Review of Anti …, 2023 - Taylor & Francis
Introduction Mucormycosis (MCR) is caused by filamentous molds within the Class
Zygomycetes and Order Mucorales. Infections can result from inhalation of spores into the …

A strategy for prevention of fungal infections in lung transplantation: role of bronchoalveolar lavage fluid galactomannan and fungal culture

S Husain, A Bhaskaran, C Rotstein, Y Li… - The Journal of Heart and …, 2018 - Elsevier
Background The optimal strategy for prevention of invasive fungal infections in lung
transplant recipients remains undetermined. We studied strategies based on …

Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis in solid organ transplant patients: a semiprospective multicenter study

B Willinger, M Lackner, C Lass-Flörl, J Prattes… - …, 2014 - journals.lww.com
Background Invasive pulmonary aspergillosis (IPA) remains an important cause of morbidity
and mortality among patients undergoing solid organ transplantation (SOT). Because of the …

Epidemiology of invasive fungal infections in lung transplant recipients on long‐term azole antifungal prophylaxis

PP Chong, CC Kennedy, MA Hathcock… - Clinical …, 2015 - Wiley Online Library
Lung transplant recipients (LTR) at our institution receive prolonged and mostly lifelong
azole antifungal (AF) prophylaxis. The impact of this prophylactic strategy on the …

Organ transplantation for cystic fibrosis

MR Morrell, SC Kiel, JM Pilewski - Seminars in Respiratory and …, 2019 - thieme-connect.com
Cystic fibrosis (CF) remains the most common indication for lung transplantation in children
and the third most common in adults and has the highest median survival posttransplant for …